Compare DCI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DCI | BIO |
|---|---|---|
| Founded | 1915 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pollution Control Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 8.7B |
| IPO Year | 1987 | N/A |
| Metric | DCI | BIO |
|---|---|---|
| Price | $102.23 | $312.40 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $98.00 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 628.2K | 184.0K |
| Earning Date | 02-26-2026 | 02-12-2026 |
| Dividend Yield | ★ 1.20% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.21 | N/A |
| Revenue | ★ $3,726,200,000.00 | $2,557,500,000.00 |
| Revenue This Year | $4.69 | $1.62 |
| Revenue Next Year | $4.71 | $2.26 |
| P/E Ratio | $31.15 | ★ N/A |
| Revenue Growth | ★ 2.37 | N/A |
| 52 Week Low | $57.45 | $211.43 |
| 52 Week High | $101.61 | $373.69 |
| Indicator | DCI | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 73.62 | 47.12 |
| Support Level | $99.29 | $306.52 |
| Resistance Level | $101.48 | $328.56 |
| Average True Range (ATR) | 1.77 | 9.16 |
| MACD | 0.90 | -0.38 |
| Stochastic Oscillator | 96.52 | 40.11 |
Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.7 billion in revenue in its fiscal 2025.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.